Effects of inserting fluorescent proteins into the α1S II–III loop: insights into excitation–contraction coupling by Bannister, Roger A. et al.
ARTICLE
The Rockefeller University Press  $30.00
J. Gen. Physiol. Vol. 134 No. 1  35–51
www.jgp.org/cgi/doi/10.1085/jgp.200910241 35 
INTRODUCTION
The skeletal muscle L-type Ca
2+ channel (1,4-dihydro-
pyridine receptor [DHPR]) serves as the voltage sensor 
for excitation–contraction (EC) coupling (Tanabe et al., 
1988), activating Ca
2+ release from the SR via RYR1 in 
response to depolarization of the plasma membrane. 
The interaction with RYR1 also increases the magnitude 
of the L-type Ca
2+ current produced by DHPR (Nakai 
et al., 1996; Grabner et al., 1999; Avila and Dirksen, 2000; 
Avila et al., 2001; Ahern et al., 2003; Sheridan et al., 
2006). Neither of these interactions depends on any ob-
vious diffusible messenger (such as entry of external 
Ca
2+), which has led to the idea that there is bidirec-
tional conformational coupling between these two pro-
teins (Tanabe et al., 1988; García and Beam, 1994; 
García et al., 1994; Nakai et al., 1998b; Grabner et al., 
1999). Moreover, freeze-fracture replicas of the plasma 
membrane at sites of junction with the SR reveal a struc-
tural  correlate  of  the  functional  interaction  between 
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DHPR and RYR1 (Block et al., 1988; Takekura et al., 
1994, 2004; Protasi et al., 2002; Sheridan et al., 2006). 
Specifically, intramembranous particles in the plasma 
membrane,  which  appear  to  represent  DHPRs,  are   
arranged into groups of four (tetrads) with spacing that 
places them in register with the four subunits of every 
other RYR1. Moreover, the distance between each DHPR 
within the tetrad (19 nm) is decreased (2 nm) by 
application  of  a  high  concentration  of  ryanodine 
(Paolini et al., 2004), which locks RYR1 in an inacti-
vated, nonconducting state (Buck et al., 1992; Zimányi 
et al., 1992). Thus, it seems quite certain that protein–
protein interactions link DHPR and RYR1.
Two basic strategies have been used in the search to 
identify the protein–protein interactions that may couple 
the DHPR and RYR1. One approach has been biochem-
ical analysis of isolated proteins. With this approach, it 
has been shown that specific regions of the DHPR bind 
to, or affect the function of, RYR1 and that specific re-
gions of RYR1 bind to DHPR. This approach has re-
vealed that segments of the 1S II–III loop (Leong and 
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In skeletal muscle, intermolecular communication between the 1,4-dihydropyridine receptor (DHPR) and RYR1 is 
bidirectional: orthograde coupling (skeletal excitation–contraction coupling) is observed as depolarization-induced 
Ca
2+ release via RYR1, and retrograde coupling is manifested by increased L-type Ca
2+ current via DHPR. A critical 
domain (residues 720–765) of the DHPR 1S II–III loop plays an important but poorly understood role in bidirec-
tional coupling with RYR1. In this study, we examine the consequences of fluorescent protein insertion into differ-
ent positions within the 1S II–III loop. In four constructs, a cyan fluorescent protein (CFP)–yellow fluorescent 
protein (YFP) tandem was introduced in place of residues 672–685 (the peptide A region). All four constructs sup-
ported efficient bidirectional coupling as determined by the measurement of L-type current and myoplasmic Ca
2+ 
transients. In contrast, insertion of a CFP–YFP tandem within the N-terminal portion of the critical domain (be-
tween residues 726 and 727) abolished bidirectional signaling. Bidirectional coupling was partially preserved when 
only a single YFP was inserted between residues 726 and 727. However, insertion of YFP near the C-terminal bound-
ary of the critical domain (between residues 760 and 761) or in the conserved C-terminal portion of the 1S II–III 
loop (between residues 785 and 786) eliminated bidirectional coupling. None of the fluorescent protein insertions, 
even those that interfered with signaling, significantly altered membrane expression or targeting. Thus, bidirec-
tional signaling is ablated by insertions at two different sites in the C-terminal portion of the 1S II–III loop. Signifi-
cantly, our results indicate that the conserved portion of the 1S II–III loop C terminal to the critical domain plays 
an important role in bidirectional coupling either by conveying conformational changes to the critical domain from 
other regions of the DHPR or by serving as a site of interaction with other junctional proteins such as RYR1.
© 2009 Bannister et al.  This article is distributed under the terms of an Attribution–Non-
commercial–Share Alike–No Mirror Sites license for the first six months after the publication 
date (see http://www.jgp.org/misc/terms.shtml). After six months it is available under a Cre-
ative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as 
described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
G
e
n
e
r
a
l
 
P
h
y
s
i
o
l
o
g
y36 1S II–III LOOP AND CFP–YFP PROBES
sion of a one-piece 1S construct lacking residues 671–690 
(the peptide As-20 region; El-Hayek and Ikemoto, 1998). 
Moreover, two-fragment 1S constructs created by dele-
tion of residues 671–690 (Flucher et al., 2002) or 671–700 
(Ahern et al., 2001a) also supported robust EC coupling. 
Although these results indicate that coupling does not 
require the presence of the peptide A region or the con-
nection of the critical domain to 1S repeat II via the pep-
tide backbone, they do not exclude a modulatory role 
for this segment of the 1S II–III loop, which has been 
recently reported to bind in vitro to a fragment of RYR1 
(residues 1,085–1,208; Cui et al., 2009; Tae et al., 2009).
It is important to note that the 1S II–III loop region 
extending from within the C-terminal portion of the criti-
cal  domain  to 1S repeat III has not been adequately 
tested because this region of the loop is overall consider-
ably conserved between 1S and the corresponding re-
gions of 1C and 1M (Wilkens et al., 2001). To examine 
more systematically the importance of different portions 
of the 1S II–III loop, we introduced perturbations at dis-
tinct sites within the loop. In particular, we introduced 
substantial extra mass (one or two fluorescent proteins) 
at various sites. The rationale for this approach is that 
one would expect that sites able to accommodate this in-
sertion without affecting function could neither directly 
interact with other junctional proteins nor undergo large 
conformational changes during EC coupling.
We have found that bidirectional coupling is not af-
fected by insertion of a tandem of fluorescent proteins 
(aggregate mass of 56 kD) in place of 1S residues 
672–685, adding support to the prevailing view that re-
gions of the 1S II–III loop flanking this insertion site do 
not undergo important conformational changes and that 
the critical domain does not interact with more proxi-
mal portions of the loop. We found that insertions lo-
cated more toward the C-terminal end of the loop had 
a much larger impact on bidirectional signaling. Thus, 
bidirectional coupling was totally abolished by insertion 
of the tandem within the critical domain’s N-terminal 
boundary (between 1S residues 726 and 727) but only 
partially ablated by insertion of a single fluorescent pro-
tein at this site. However, bidirectional signaling was 
essentially ablated by the insertion of a single yellow fluo-
rescent protein (YFP) near the C-terminal boundary of 
the critical domain (between 1S residues 760 and 761). 
This also occurred when a single YFP was inserted between 
1S residues 785 and 786, which is C terminal to the criti-
cal domain and well conserved between 1S, 1C, and 
1M. Control experiments indicated that these insertions 
did not interfere with membrane expression or targeting 
to peripheral junctions. Thus, our results raise the pos-
sibility that the signaling functions of the critical domain 
depend on its linkage to 1S repeat III via the C-terminal 
portion of the 1S II–III loop. Alternatively, this con-
served region of the 1S II–III loop may be an important 
site of protein–protein interaction required for signaling.
MacLennan,  1998a),  1S  III–IV  loop  (Leong  and   
MacLennan, 1998b), and the proximal 1S C terminus 
(Sencer et al., 2001) bind to fragments of RYR1 and 
that segments of RYR1 bind to DHPR subunits (Sencer 
et al., 2001; Cheng et al., 2005). An important limita-
tion of such biochemical approaches is that they may 
reveal interactions between segments of proteins that 
do not interact within living cells. Moreover, the inter-
actions revealed by these biochemical approaches have 
often been difficult to reconcile with results obtained by 
functional analyses of myotubes after expression of 
cDNAs encoding wild-type or engineered DHPRs or RYRs 
(Beam and Horowicz, 2004). For the functional analysis 
of the DHPR, the focus has been on the 1S and 1a sub-
units because bidirectional signaling is little affected by 
knockout/knockdown of the 1 (Freise et al., 2000; Ursu 
et al., 2001) or 2-1 (Obermair et al., 2005, 2008; García 
et al., 2007; Gach et al., 2008; Tuluc et al., 2009) sub-
units. Expression of cDNAs in myotubes null for endog-
enous  1  has  revealed  that  the  C  terminus  of  1a  is 
important for EC coupling (Beurg et al., 1999; Sheridan 
et al., 2003a,b, 2004). Likewise, expression of cDNAs in 
dysgenic (1S null) myotubes has shown that EC cou-
pling is critically dependent on the 1S II–III loop (see 
next paragraph) and is also influenced by the 1S III–IV 
loop (Weiss et al., 2004; Bannister et al., 2008b).
The 1S II–III loop substituted into the corresponding 
region of the cardiac DHPR 1C subunit confers skeletal-
type coupling (Tanabe et al., 1990; Carbonneau et al., 
2005), and, conversely, substitution into an 1S back-
bone with the II–III loop of 1C (SkLC; Grabner et al., 
1999) or 1M (SkLM; Wilkens et al., 2001; Kugler et al., 
2004b) abolishes bidirectional signaling. However, bidi-
rectional signaling is restored when a critical domain of 
the 1S II–III loop (residues 720–765; Nakai et al., 1998b) 
is reintroduced within SkLC or SkLM (Grabner et al., 
1999; Wilkens et al., 2001; Kugler et al., 2004b). Within the 
critical domain, a central region (1S residues 737–751) 
contains the binding site (residues 737–744) for mAb 
1A (Kugler et al., 2004a) and an adjacent cluster of neg-
ative charges (residues 744–751). Within this central 
region, mutation of Ala
739, Phe
741, Pro
742, or Asp
744 to its 
corresponding 1C residue reduces both skeletal-type EC 
coupling and the binding of mAb 1A, and the secondary 
structure of residues 744–751 also appears to be impor-
tant for skeletal-type EC coupling (Kugler et al., 2004a,b). 
On the basis of these results, it has been proposed that 
some portion of 1S residues 737–751 may bind to and 
activate RYR1 in response to conformational changes of 
other regions of the DHPR (Kugler et al., 2004b).
If conformationally driven interactions between re-
gions of the 1S II–III loop and RYR1 are important for 
bidirectional signaling, it is important to understand 
how those interactions are coupled to other regions of 
the DHPR. Previous work (Ahern et al., 2001b) has shown 
that skeletal-type EC coupling is preserved after expres-  Bannister et al. 37 
The  resultant  PCR  product  was  subcloned  into  a  YFP-1S  
(Papadopoulos et al., 2004) plasmid that contained a NotI site 
between the 1S triplets encoding Pro
760 and Leu
761 introduced by 
site-directed mutagenesis with QuikChange primers 5-GCCCCC-
GAC  CGCGG  CCGCTGGCCCGAGCTGC-3 (forward) and 5-GCAG-
CTCGGCC  AGCGGCCGCGGTCGGGGGC-3  (reverse).  This 
plasmid was then digested with HindIII and MfeI to excise the 
segment containing 1S(760-YFP-761), from which the sequence 
encoding the N-terminal YFP had been removed, and was sub-
cloned into pEYFP-N1 cut with HindIII and MfeI.
1S(785-YFP-786). 1S(785-YFP-786) encodes (in order) (a) 1S 
residues 1–785, (b) a four-residue linker, (c) YFP, (d) a 22-residue 
linker, and (e) 1S residues 786–1,860. PCR was used to generate 
a  YFP/linker  cDNA  with  5  and  3  AgeI  restriction  sites  from 
1S(726-YFP-727). The forward primer was 5-GCGCGCGACCG-
GTGTCGCCACCATGGTGAGCAAGG-3, and the reverse primer 
was  5-GCGCGCGACCGGTCGGGCCCGCGGTACCGT-3.  An 
812-bp PCR product encoding YFP and the aforementioned link-
ers was subsequently cut with AgeI and ligated into the untagged 
1S expression vector in which a GGT triplet (encoding Gly) had 
been introduced to form a unique AgeI recognition sequence be-
tween the triplets encoding Thr
785 and Asn
786. Restriction digests 
and sequencing were used to verify each cDNA construct.
Expression of cDNA
All procedures involving mice were approved by the University of 
Colorado Denver Institutional Animal Care and Use Committee. 
Primary cultures of phenotypically normal (+/+ or +/mdg) or dys-
genic (mdg/mdg) myotubes were prepared from newborn mice as 
described previously (Beam and Franzini-Armstrong, 1997). For 
electrophysiological experiments, myoblasts were plated into 35-mm 
plastic  culture  dishes  (Falcon)  coated  with  entactin–collagen 
IV–laminin (Millipore). Myoblasts destined for immunocytochem-
istry were plated into 35-mm culture dishes with entactin–collagen 
IV–laminin–coated glass coverslip bottoms (MatTek). Cultures were 
grown for 6–7 d in a humidified 37°C incubator with 5% CO2 in 
Dulbecco’s modified Eagle’s medium (Mediatech) supplemented 
with 10% fetal bovine serum/10% horse serum (Hyclone Laborato-
ries). This medium was then replaced with differentiation medium 
(Dulbecco’s  modified  Eagle’s  medium  supplemented  with  2% 
horse serum). 2–4 d after the shift to differentiation medium, single 
nuclei  were  microinjected  with  cDNA.  For  one-piece  constructs 
(1S(671-CFP-YFP-686), 1S(726-CFP-YFP-727), 1S(726-YFP-727), 
1S(760-YFP-761), or 1S(785-YFP-786)), myotubes to be used in 
electrophysiological experiments were injected with 100 ng/µl 
cDNA, and myotubes to be immunostained were injected with 
60 ng/µl cDNA. For electrophysiology on two-piece constructs, the 
injection solution contained 60 ng/µl 1S(671) hemichannel cDNA 
and 100 ng/µl (686)1S hemichannel cDNA. Only myotubes ex-
hibiting YFP fluorescence were used in experiments.
Measurement of ionic currents
For electrophysiological experiments, myotubes were examined 2 d 
after injection. Pipettes were fabricated from borosilicate glass 
and had resistances of 2.0 MΩ when filled with internal solu-
tion, which consisted of 140 mM Cs-aspartate, 10 mM Cs2-EGTA, 
5 mM MgCl2, and 10 mM HEPES, pH 7.4, with CsOH. The stan-
dard external solution contained 145 mM TEA-Cl, 10 mM CaCl2, 
0.003 mM tetrodotoxin, and 10 mM HEPES, pH 7.4, with TEA-OH. 
In some experiments, 10 mM MgCl2 was substituted for 10 mM 
CaCl2 in the external solution. Linear capacitative and leakage 
currents were determined by averaging the currents elicited by 11 
30-mV hyperpolarizing pulses from a holding potential of 80 mV. 
Test currents were corrected for linear components of leak and 
capacitive current by digital scaling and subtraction of this aver-
age control current. Electronic compensation was used to reduce 
MATERIALS AND METHODS
Molecular biology
The constructions of YFP-1S, 1S(671-CFP-YFP-686), and 1S(671-
CFP-YFP) + (686)1S were previously described in Papadopoulos 
et al. (2004). All residue numbers refer to the amino sequence of 
rabbit 1S (GenBank/EMBL/DDBJ accession no. X05921).
1S(671-CFP) and (YFP-686)1S. 1S(671-CFP) and (YFP-686)1S en-
code, respectively, (a) 1S residues 1–671 followed by an 11-residue 
linker and by cyan fluorescent protein (CFP) and (b) YFP followed 
by a 12-residue linker and by 1S residues 686–1,860. To make 
1S(671-CFP), the sequence encoding 1S 1–671 (2,039 bp) was ex-
cised from 1S(671-CFP-YFP) with HindIII and KpnI and ligated 
into the polylinker of the mammalian expression vector pECFP-N1 
(Clontech  Laboratories,  Inc.)  cleaved  by  HindIII  and  KpnI 
(4,706-bp fragment). To make (YFP-686)1S, the sequence encom-
passing the region encoding YFP (769 bp) was excised from pEYFP- 
C1 (Clontech Laboratories, Inc.), which had been modified to bring 
the HindIII site into frame for the subsequent cloning procedure. 
Specifically, an XhoI–SalI fragment of the pEYFP-N1 polylinker en-
compassing the HindIII site was reversed by ligation into the com-
patible NheI and HindIII, which are sites of (686)1S (Papadopoulos 
et al., 2004) opened by NheI and HindIII (7,843 bp).
1S(671)  and  (CFP-YFP-686)1S.  1S(671)  and  (CFP-YFP-686)1S 
encode, respectively, (a) 1S residues 1–671 followed by a 12-resi-
due linker and (b) the CFP–YFP tandem (separated by a 23-residue 
linker) followed by a 12-residue linker and by 1S residues 686–
1,860. To make untagged 1S(671), the sequence encoding 1S(671) 
(2,039 bp) was removed from 1S(671-CFP) (see previous para-
graph) with HindIII and KpnI and inserted into the backbone 
(3,973 bp) of untagged (686)1S, from which the sequence encod-
ing (686)1S had been excised by digestion with HindIII and KpnI. 
To make (CFP-YFP-686)1S, the sequence encoding CFP (794 bp) 
was excised from pECFP-C1 (Clontech Laboratories, Inc.) with 
NheI and XmaI and ligated into (YFP-686)1S (see previous para-
graph) cleaved with NheI and AgeI (8,243 bp). XmaI and AgeI 
cleavage sites are compatible for relegation.
1S(726-CFP-YFP-727). 1S(726-CFP-YFP-727) encodes (in order)
(a) 1S residues 1–726, (b) a four-residue linker, (c) CFP–YFP, 
(d) a 21-residue linker, and (e) 1S residues 727–1,860. CFP-YFP-1a 
(Papadopoulos  et  al.,  2004)  was  cut  with  AgeI  and  XmaI.  A 
1,574-bp fragment encoding the CFP–YFP tandem and the afore-
mentioned linkers were subsequently ligated into the untagged 
1S expression vector (Papadopoulos et al., 2004) in which an AgeI 
recognition sequence was introduced between the triplets encod-
ing Glu
726 and Ser
727 via site-directed PCR mutagenesis (QuikChange; 
Agilent Technologies).
1S(726-YFP-727). 1S(726-YFP-727) encodes (in order) (a) 1S resi-
dues 1–726, (b) a four-residue linker, (c) YFP, (d) a 21-residue linker, 
and (e) 1S residues 727–1,860. A 786-bp sequence encoding YFP was 
excised from pEYFP-C1 using AgeI and XmaI. The resultant frag-
ment was ligated into the untagged 1S expression vector in which an 
AgeI recognition sequence was introduced between the triplets en-
coding Glu
726 and Ser
727 via site-directed PCR mutagenesis.
1S(760-YFP-761). 1S(760-YFP-761) encodes (in order) (a) 1S 
residues 1–760, (b) a single-residue linker, (c) YFP, (d) a three-
residue linker, and (d) 1S residues 761–1,860. PCR was used to 
generate a YFP cDNA with 5 and 3 NotI restriction sites from 
pEYFP-N1.  The  forward  primer  was  5-GCGCGCGGCCG-
CAAATGGTGAGCAAGGGCG-3, and the reverse primer was 
5-GCGCGCGCGGCCGCTTCTTGTACAGCTCGTCCATGCC-3. 38 1S II–III LOOP AND CFP–YFP PROBES
F/F = [F/F]max/[1 + exp{(V  VF)/kF}],  (2)
where (F/F)max is the maximal fluorescence change, VF is the 
potential causing half the maximal change in fluorescence, and 
kF is a slope parameter. In the cases of 1S(760-YFP-761) and 1S(785-
YFP-786), the F/Fmax-V relationship was fit by
F/F = [F/F]max × exp{0.5((V  Vc)/b)
2},  (3)
where (F/F)max is the maximal fluorescence change and Vc and b 
are fit parameters (Wilkens and Beam, 2003).
Measurement of charge movements
For measurement of intramembrane charge movements, ionic cur-
rents were blocked by the addition of 0.5 mM CdCl2 + 0.1 mM LaCl3 
to the standard extracellular recording solution. All charge move-
ments were corrected for linear cell capacitance and leakage cur-
rents using a P/8 subtraction protocol (Bannister et al., 2008a,b). 
Filtering was at 2 kHz (eight-pole Bessel filter; Frequency Devices, 
Inc.), and digitization was at 20 kHz. Voltage clamp command 
pulses were exponentially rounded with a time constant of 50–500 µs, 
and the prepulse protocol (Adams et al., 1990) was used to reduce 
the contribution of gating currents from voltage-gated Na
+ chan-
nels and T-type Ca
2+ channels. The integral of the ON transient 
(Qon) for each test potential (V) was fitted according to
Qon = Qmax/{1 + exp[(V  VQ)/kQ]},  (4)
where Qmax is the maximal Qon, VQ is the potential causing move-
ment of half the maximal charge, and kQ is a slope parameter.
Electrically evoked contractions
Contractions were elicited by 20-ms, 100-V stimuli applied via an 
extracellular pipette that contained 150 mM NaCl and was placed 
near intact myotubes expressing constructs of interest. The myo-
tubes were bathed in Rodent Ringer’s solution (146 mM NaCl, 
5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM HEPES, and 11 mM 
glucose, pH 7.4, with NaOH). Contractions were assayed by the 
the effective series resistance (usually to <1 MΩ) and the time 
constant for charging the linear cell capacitance (usually to <0.5 ms). 
Ionic currents were filtered at 2 kHz and digitized at 10 kHz. 
To measure macroscopic L-type current in isolation, a 1-s pre-
pulse to 20 mV followed by a 100-ms repolarization to 50 mV 
was administered before the test pulse (prepulse protocol; Adams 
et al., 1990) to inactivate T-type Ca
2+ channels. Cell capacitance 
was determined by integration of a transient from 80 to 70 mV 
using Clampex 8.0 (MDS Analytical Technologies) and was used 
to normalize current amplitudes (pA/pF). Current–voltage (I-V) 
curves were fitted using the following equation:
I = Gmax × (V  Vrev)/[1 + exp{(V  V1/2)/kG}],   (1)
where I is the current for the test potential V, Vrev is the reversal 
potential, Gmax is the maximum Ca
2+ channel conductance, V1/2 is 
the half-maximal activation potential, and kG is the slope factor. 
All  electrophysiological  experiments  were  performed  at  room 
temperature (25°C).
Measurement of intracellular Ca
2+ transients
Changes in intracellular Ca
2+ were recorded with Fluo-3 (Invitrogen). 
The salt form of the dye was added to the standard internal solution 
for a final concentration of 200 µM. After entry into the whole cell 
configuration, a waiting period of >5 min was used to allow the dye to 
diffuse into the cell interior. A 100-W mercury illuminator and a set 
of fluorescein filters were used to excite the dye present in a small 
rectangular region of the voltage-clamped myotube. A computer-
controlled shutter was used to block illumination in the intervals be-
tween test pulses. Fluorescence emission was measured by means of a 
fluorometer apparatus (Biomedical Instrumentation Group, Univer-
sity  of  Pennsylvania).  The  average  background  fluorescence  was 
quantified before bath immersion of the patch pipette. Fluorescence 
data are expressed as the total change in fluorescence (F/F), where 
F represents the change in peak fluorescence from baseline during 
the test pulse and F is the fluorescence immediately before the test 
pulse  minus  the  average  background  (non–Fluo-3)  fluorescence. 
Unless otherwise noted, the peak value of the fluorescence change 
(F/F) for each test potential (V) was fitted according to
TABLE I
1S fluorescent protein construct conductance and intramembrane charge movement
Construct G-V Q-V Gmax/Q
Gmax V1/2 kG Qmax VQ kQ
nS/nF mV mV nC/F mV mV nS/pC
1S-YFP
a 140 ± 5 (37) 31.2 ± 0.8 8.1 ± 0.2 6.0 ± 0.4 (8) 3.2 ± 2.0 9.0 ± 0.7 33
1S(671-CFP-YFP) + (686)1S 174 ± 13 (20) 36.0 ± 0.9 7.4 ± 0.3 4.2 ± 0.8 (7) 9.5 ± 4.5 9.2 ± 0.6 54
1S(671) + (CFP-YFP-686)1S 144 ± 13 (20) 35.5 ± 1.1 7.8 ± 0.3 3.5 ± 1.4 (4) 11.1 ± 6.6 9.3 ± 1.4 58
1S(671-CFP) + (YFP-686)1S 164 ± 15 (18) 36.0 ± 1.1 7.4 ± 0.4 4.4 ± 1.1 (5) 4.8 ± 5.4 5.3 ± 2.6 48
1S(671-CFP-YFP-686) 182 ± 11 (33) 33.9 ± 1.1 7.3 ± 0.3 6.3 ± 0.8 (7) 3.1 ± 0.8 11.3 ± 0.7 34
1S(726-CFP-YFP-727) 67 ± 5 (30)
b 38.5 ± 1.8
d 10.4 ± 0.7
b 5.4 ± 0.9 (6) 12.2 ± 4.1
d 11.7 ± 1.4 15
1S(726-YFP-727) 116 ± 11 (15)
b 35.1 ± 2.2 9.7 ± 0.7
b 6.9 ± 0.6 (6) 12.1 ± 1.4
b 13.4 ± 0.9 20
1S(760-YFP-761) 102 ± 10 (12)
b 34.1 ± 0.9 9.2 ± 0.7
c 8.0 ± 1.6 (5) 7.6 ± 1.8
c 14.0 ± 1.4 15
1S(785-YFP-786) 72 ± 10 (12)
b 38.9 ± 3.4 9.5 ± 1.7 5.2 ± 0.8 (5) 11.3 ± 4.8 12.5 ± 1.0 17
Uninjected dysgenic  
  myotubes
no inward  
current (17)
no inward  
current (17)
no inward  
current (17)
1.0 ± 0.2 (6) 5.0 ± 4.6 9.6 ± 3.0 ND
Data are given as mean ± SEM, with the numbers in parentheses indicating the number of myotubes tested. See Materials and methods for fits. For all of 
the data given, the calculated average voltage error was <5 mV. Significant differences between 1S(671-CFP-YFP-686) and the other individual one-piece 
constructs (i.e., 1S(726-CFP-YFP-727), 1S(726-YFP-727), 1S(760-YFP-761), and 1S(785-YFP-786)) are indicated.
a1S-YFP data from Bannister and Beam (2005) are included for comparison.
bP < 0.001 by t test.
cP < 0.01 by t test.
dP < 0.05 by t test.  Bannister et al. 39 
E and F), near the C-terminal edge of the critical domain 
(Fig. 1 G), and the conserved segment of the 1S II–III 
loop that intervenes between the critical domain and re-
peat III (Fig. 1 H).
Insertions into the peptide A region
Previous work monitored the fluorescence resonance en-
ergy transfer efficiency of an 56-kD CFP–YFP tandem 
inserted in place of the peptide A region of the 1S II–III 
loop (residues 671–686) as an indicator of spatial envi-
ronment (Papadopoulos et al., 2004). The fluorescence 
resonance energy transfer efficiency showed a small de-
pendence on whether or not RYR1 was present when 
CFP–YFP replaced 1S residues 672–685 in a one-piece 
construct (Fig. 1 A) but no dependence when the tandem 
movement of an identifiable portion of a myotube across the vi-
sual field.
Immunohistochemistry
2 d after the injection, myotubes were washed twice in Ca
2+/Mg
2+-
free Ringer’s solution (146 mM NaCl, 5 mM KCl, 10 mM HEPES, 
and 11 mM glucose, pH 7.4, with NaOH) and fixed in 4% para-
formaldehyde solution in PBS (Sigma-Aldrich) for 20 min. Myo-
tubes were then permeabilized with 0.1% Triton X-100/PBS for 
30 min. After another PBS wash, nonspecific reactivity was blocked 
by application of 1% BSA/PBS for 2 h. The primary antibody 
(mouse anti-1S, 1:2,000; Thermo Fisher Scientific; also referred 
to  as  mAb  1A)  was  applied  overnight  at  room  temperature 
(25°C) in a dark, humid environment. The next day, myotubes 
were again washed with 1% BSA/PBS. The secondary antibody 
(Alexa Fluor 568–conjugated goat anti–mouse IgG, 1:4,000; Invit-
rogen) was applied in the dark for 1 h at room temperature. Ex-
cess secondary antibody was removed with three 1% BSA/PBS 
washes. Finally, immunostained myotubes were rinsed with PBS.
Confocal microscopy
Immunostained myotubes were examined in PBS using a confo-
cal laser-scanning microscope (LSM 510 META; Carl Zeiss, Inc.). 
An area of 500–2,500 µm
2 was selected from the field of view (63× 
1.4 NA oil immersion objective), which included the myotube 
and also an adjacent noncellular region for measurement of back-
ground fluorescence. YFP was excited with the 488-nm line of an 
argon laser (30-mW maximum output, operated at 50% or 6.3 A), 
and Alexa Fluor 568 was excited with a separate sweep of the 
543-nm line from a HeNe laser (1-mW maximum output, oper-
ated at 100%), which were directed to the cell via a 488/543-nm 
dual dichroic mirror. The emitted YFP fluorescence was directed 
to a photomultiplier equipped with a 505–530 band-pass filter 
(Chroma Technology Corp.). For Alexa Fluor 568, the emitted 
fluorescence was directed to a photomultiplier equipped with a 
560-nm long-pass filter. Confocal fluorescence intensity data were 
recorded as the average of four line scans per pixel and digitized 
at 8 bits, with photomultiplier gain adjusted such that maximum 
pixel intensities were no more than 70% saturated.
Analysis
For calculation of Gmax/Q ratios, Gmax was obtained by Eq. 1, 
whereas Q was derived by subtracting the average maximal charge 
movement of dysgenic myotubes (Qdys) from the average total 
Qmax, where Qdys = 1.0 nC/F (n = 6; Table I). Figures were made 
using the software program SigmaPlot (version 7.0 or 11.0; SSPS 
Inc.). All data are presented as mean ± SEM. Statistical compari-
sons were made by ANOVA or by unpaired, two-tailed t test (as 
appropriate), with P < 0.05 considered significant.
Online supplemental material
Fig. S1 confirms that 1S(726-YFP-727) partially supports skeletal-
type EC coupling. Myoplasmic Ca
2+ transients and L-type currents 
were recorded with 10 mM Mn
2+ substituted for 10 mM Ca
2+ in the 
bath solution. Online supplemental material is available at http://
www.jgp.org/cgi/content/full/jgp.200910241/DC1.
RESULTS
The overall aim of this study was to determine how per-
turbing the DHPR 1S II–III loop with inserted fluores-
cent proteins affects bidirectional interactions with RYR1. 
These constructs are illustrated in Fig. 1 and represent 
insertions into the peptide A region (Fig. 1, A–D), into 
the N-terminal portion of the critical domain (Fig. 1, 
Figure 1.  Schematic diagrams of the fluorescent protein 1S fu-
sion constructs. The red segment of the 1S II–III loop represents 
the EC coupling critical domain (1S residues 720–765; Nakai   
et al., 1998b). The linker sequences (see Materials and methods) 
connecting CFP and YFP to one another and linking the fluo-
r  escent proteins to 1S are indicated by wavy lines. (A–D) 1S 
constructs in which a CFP–YFP tandem was substituted for 1S 
residues 672–685 (i.e., the tandem replaced the peptide A region). 
(E and F) 1S constructs in which either the CFP–YFP tandem 
(E) or a single YFP (F) was introduced between 1S residues 726 
and 727. This position lies just inside the N-terminal portion of 
the critical domain. (G) 1S construct in which YFP was inserted 
in between residues 760 and 761. This position lies just inside the 
C-terminal edge of the critical domain. (H) 1S construct in which 
YFP was inserted between residues 785 and 786. This position lies 
in the highly conserved C-terminal region of the 1S II–III loop 
between the critical domain and 1S repeat III.40 1S II–III LOOP AND CFP–YFP PROBES
Fig. 2 C), despite having similar membrane expression (as 
assessed by intramembrane charge movement; P > 0.05, 
ANOVA; Table I). However, it is possible that some of the 
charge movement for the two-piece constructs was pro-
duced by 1S I–II hemidomains unpartnered with 1S III–IV 
hemidomains (Ahern et al., 2001a; Flucher et al., 2002).
Dysgenic myotubes expressing each of the four sets of 
constructs  with  the  CFP–YFP  tandem  introduced  in 
place of the peptide A region produced contractions 
in response to extracellular electrical stimuli (Table II).
  Depolarization-triggered  myoplasmic  Ca
2+  transients 
for these constructs are shown in Fig. 3. 1S(671-CFP-
YFP-686) triggered robust Ca
2+ transients ([F/F]max = 
0.69 ± 0.12; n = 7) with an amplitude that had a sigmoi-
dal dependence on test potential (Table II and Fig. 3 A), 
a signature characteristic of skeletal-type EC coupling 
(García and Beam, 1994; García et al., 1994). Likewise, 
1S(671-CFP-YFP) + (686)1S ([F/F]max = 0.61 ± 0.08; 
n = 9) and 1S(671-CFP) + (YFP-686)1S ([F/F]max = 
0.93 ± 0.14; n = 7) also served as effective voltage sensors 
for EC coupling (Table II and Fig. 3, B and D). 1S(671) + 
(CFP-YFP-686)1S had a slightly reduced ability to trig-
ger myoplasmic Ca
2+ release ([F/F]max = 0.48 ± 0.07; 
n = 6; P < 0.05, ANOVA; Fig. 3 C and Table II). This slight 
reduction in ability to mediate EC coupling mirrored 
the reduced L-type current produced by 1S(671) + (CFP-
YFP-686)1S (Fig. 2 C). However, the main conclusion 
that can be drawn from the experiments illustrated in 
Figs. 2 and 3 is that introduction of the CFP–YFP tandem 
was fused to the C terminus of an 1S I–II hemichannel 
(after 1S residue 671) and was coexpressed with an 1S 
III–IV hemichannel (beginning at 1S residue 686;   
Fig. 1 B). Thus, in this study, we examined these two con-
structs in more detail as well as two additional constructs 
centered on this location. In 1S(671) + (CFP-YFP-686)1S, 
the division was made before the tandem (Fig. 1 C), and 
in 1S(671-CFP) + (YFP-686)1S, the tandem was split, 
and the fluorescent proteins resided separately on each 
hemidomain (Fig. 1 D).
L-type Ca
2+ currents for the four sets of constructs after 
expression in dysgenic myotubes are shown in Fig. 2. The 
one-piece construct 1S(671-CFP-YFP-686) produced 
large-amplitude L-type Ca
2+ currents (6.6 ± 0.5 pA/pF 
at 50 mV; n = 33) with an I-V relationship (V1/2 = 33.9 ± 
1.1 mV; Fig. 2 A) that were similar to those reported pre-
viously  for  other  fluorescent  protein–tagged  DHPRs 
(Table I; Grabner et al., 1998; Wilkens et al., 2001, Flucher 
et al., 2002; Papadopoulos et al., 2004; Bannister and 
Beam, 2005; Bannister et al., 2008b). The construct pairs 
1S(671-CFP-YFP) + (686)1S and 1S(671-CFP) + (YFP-
686)1S produced currents similar to those of 1S(671-
CFP-YFP-686) in both magnitude (6.2 ± 0.6 pA/pF [n = 
20] and 5.8 ± 0.8 pA/pF [n = 18], respectively; P > 0.05, 
ANOVA) and voltage dependence (P > 0.05, ANOVA; 
Table I). The construct pair 1S(671) + (CFP-YFP-686)1S 
produced currents with a peak current density (4.5 ± 
0.5 pA/pF at 50 mV; n = 20) slightly lower relative to the 
other two hemichannel combinations (P > 0.05, ANOVA; 
Figure 2.  L-type currents are lit-
tle affected by replacement of 1S 
residues 672–685 with a CFP–YFP 
tandem.  Peak  I-V  relationships 
are shown for dysgenic myotubes 
expressing 1S(671-CFP-YFP-686) 
(A), 1S(671-CFP-YFP) + (686)1S 
(B), 1S(671) + (CFP-YFP-686)1S 
(C),  and  1S(671-CFP)  +  (YFP-
686)1S (D). Currents were evoked   
at 0.1 Hz by 200-ms test poten-
tials  ranging from 20 through 
80 mV in 10-mV increments after 
a prepulse protocol (Adams et al., 
1990). Current amplitudes were 
normalized by linear cell capaci-
tance (pA/pF). Representative 
current  families  (test  potentials 
of  20,  0,  20,  and  40  mV)  for 
each construct are shown in the 
insets.  Vertical  scale  bar,  5  pA/
pF; horizontal scale bar, 50 ms. 
The smooth I-V curves are plot-
ted according to Eq. 1, with the 
best fit parameters for each plot 
presented in Table I. Error bars 
represent ±SEM.  Bannister et al. 41 
1S II–III loop insertions distal to the peptide A region
We  next  probed  the  effects  of  insertions  at  more   
C-terminal sites of the loop (Fig. 1, E-H). One obvious 
in place of 1S residues 672–685 had little or no effect 
on the ability of DHPR to conduct L-type Ca
2+ current 
or to support EC coupling.
Figure 3.  EC coupling is little affected 
by replacement of 1S residues 672–
685 with a CFP–YFP tandem. F/F-V 
relationships are shown for dysgenic 
myotubes expressing 1S(671-CFP-YFP-
686) (A), 1S(671-CFP-YFP) + (686)1S 
(B), 1S(671) + (CFP-YFP-686)1S (C), 
and 1S(671-CFP) + (YFP-686)1S (D). 
Transients were elicited at 0.1 Hz by 
200-ms  test  potentials  ranging  from   
20  through  80  mV  in  10-mV  incre-
ments  after  a  prepulse  protocol   
(Adams  et  al.,  1990).  The  smooth 
F/F-V curves are plotted according 
to Eq. 2, with the best fit parameters 
for  each  plot  presented  in  Table  II. 
Representative transient families (test 
potentials of 20, 0, 20, 40, and 60 mV) 
are shown for each construct in the 
insets.  Vertical  scale  bar,  0.5  F/F; 
horizontal scale bar, 25 ms. Error bars 
represent ±SEM.
TABLE II
Ability of fluorescent protein-tagged DHPRs to restore EC coupling
Construct F/F-V Contracting cells/ 
number tested
[F/F]max VF kF
mV mV
1S-YFP
a 0.58 ± 0.09 (15) 6.6 ± 1.6 4.7 ± 0.4 41/47
1S(671-CFP-YFP) + (686)1S 0.61 ± 0.08 (9) 0.4 ± 1.5 3.7 ± 0.4 9/11
b
1S(671) + (CFP-YFP-686)1S 0.48 ± 0.07 (6) 7.1 ± 2.0 3.7 ± 0.4 12/15
1S(671-CFP) + (YFP-686)1S 0.93 ± 0.14 (7) 7.8 ± 1.5 4.1 ± 0.4 10/25
1S(671-CFP-YFP-686) 0.69 ± 0.12 (7) 0.3 ± 2.7 4.9 ± 1.1 26/32
1S(726-CFP-YFP-727) No fit (12) No fit No fit 0/52
1S(726-YFP-727) 0.19 ± 0.08 (7)
c 11.9 ± 3.2
d 10.0 ± 2.8
d 5/56
1S(726-YFP-727) (10 mM Mg
2+ external) 0.29 ± 0.17 (4) 4.4 ± 6.0 9.1 ± 2.0 ND
1S(760-YFP-761) See legend (6) See legend See legend 0/72
1S(785-YFP-786) No fit (3) No fit No fit 0/29
Uninjected dysgenic myotubes No fit (8) No fit No fit 0/100
Data are given as mean ± SEM, with the numbers in parentheses indicating the number of myotubes tested. All F/F-V data given were fit with Eq. 2 except 
for 1S(760-YFP-761). The F/F-V relationship for 1S(760-YFP-761) was best fit by the Gaussian function F/F = [F/F]max × exp{0.5(V  Vo/b)
2}, where 
[F/F]max = 0.1, Vc = 49.2 mV, and b = 25.7 mV (Eq. 3). “No fit” indicates that the F/F-V relationship could not be well fit by either Eq. 2 or Eq. 3 for the 
number of myotubes indicated. Significant differences between 1S(671-CFP-YFP-686) and the other individual one-piece constructs that were fit by Eq. 2 
(i.e., 1S(726-YFP-727)) are indicated.
a1S-YFP data from Bannister and Beam (2005) are included for comparison.
b1S(671-CFP-YFP) + (686)1S contraction data were obtained from Papadopoulos et al. (2004).
cP < 0.005 by t test.
dP < 0.05 by t test.42 1S II–III LOOP AND CFP–YFP PROBES
were  replaced  by  nonconserved  sequence  from  1M. 
Thus, we sought to determine whether bidirectional sig-
naling would be affected by larger structural perturba-
tions within this region. In contrast to insertion in the 
peptide A region, insertion of the CFP–YFP tandem 
between 1S II–III loop residues 726 and 727, 1S(726-
CFP-YFP-727), essentially eliminated bidirectional inter-
actions with RYR1 (Fig. 5 A). Thus, 1S(726-CFP-YFP-727) 
produced currents that were much smaller than those 
of 1S(671-CFP-YFP-686) (Fig. 5 B and Table I) despite 
producing similar intramembrane charge movements 
(Fig. 4, A and B; and Table I). Furthermore, 1S(726-
CFP-YFP-727)  triggered  only  barely  detectable  Ca
2+ 
transients in the 12 myotubes examined (Fig. 5 C). Like-
wise, neither spontaneous nor evoked contractions were 
observed in dysgenic myotubes expressing 1S(726-CFP-
YFP-727) (n = 52; Table II).
To determine the effects of introducing a smaller mass 
at this site, we constructed and characterized an 1S in 
which a single YFP (27 kD) was inserted after residue 
726 (1S(726-YFP-727)). In contrast to 1S(726-CFP-YFP-
727),  partial  bidirectional  signaling  occurred  for 
concern was that these perturbations of the II–III loop 
might impair expression of the constructs. Thus, we used 
measurements of membrane-bound charge movements as 
an indication of membrane expression. These measure-
ments showed that the constructs 1S(726-CFP-YFP-727), 
1S(726-YFP-727), 1S(760-YFP-761), and 1S(785-YFP-786) 
all produced charge movements similar in magnitude to 
those of 1S(671-CFP-YFP-686) (P < 0.05, ANOVA; Table I 
and Fig. 4, A–E), which was able to mediate robust EC 
coupling and L-type Ca
2+ current.
Consequences of fluorescent protein insertion between 
1S residues 726 and 727
Based on chimeras of 1S and 1C (Nakai et al., 1998b), 
residues 720–765 were found to constitute a critical do-
main for skeletal-type EC coupling, although it is impor-
tant to note that such chimeric constructs do not allow 
one to deduce precise boundaries. Indeed, subsequent 
work with chimeras of 1S and the Musca domestica (com-
mon house fly) muscle homologue 1M (Kugler et al., 
2004b) indicated that skeletal-type EC coupling could 
be produced by constructs in which 1S residues 720–733 
Figure  4.  Introduction  of  fluorescent  pro-
teins  within  either  the  critical  domain  or 
the  conserved  C-terminal  region  of  the  1S 
II–III  loop  does  not  greatly  perturb  DHPR 
membrane  expression.  Q-V  relationships 
are shown for dysgenic myotubes expressing 
1S(671-CFP-YFP-686)  (A),  1S(726-CFP-YFP-
727) (B), 1S(726-YFP-727) (C), 1S(760-YFP-
761) (D), and 1S(785-YFP-786) (E). Charge 
movements were measured with 20-ms de-
polarizations from 50 mV in the presence 
of Cd
2+ and La
3+. Q-V relationships were fit by 
Eq. 4; the best fit parameters for each plot 
are presented in Table I. Error bars repre-
sent ±SEM.  Bannister et al. 43 
These results indicate that bidirectional coupling was 
partially restored by 1S(726-YFP-727), although both 
orthograde and retrograde coupling were impaired.
Bidirectional coupling with RYR1 is disrupted in  
1S(760-YFP-761)
With the knowledge that the triad junction can accom-
modate insertion of a single YFP near the N-terminal 
boundary of the critical domain, we next tested whether 
introduction of YFP near the C-terminal boundary of this 
region, 1S(760-YFP-761), would also partially spare bidi-
rectional signaling. This construct produced small Ca
2+ 
currents and transients (Fig. 6 A). On average, 1S(760-
YFP-761) produced Ca
2+ currents that were about half the 
magnitude of those for 1S(671-CFP-YFP-686) (Fig. 6 B). 
However, 1S(760-YFP-761) produced somewhat larger 
charge movements than the other clones examined (Fig. 4 
and Table I). If this increased membrane expression is 
taken into account, the magnitude of the currents pro-
duced by 1S(760-YFP-761) differed little from those of 
1S(726-YFP-727) (Fig. 5 D), although this signaling 
was compromised compared with 1S(671-CFP-YFP-686). 
Thus,  L-type  current  density  was  more  than  twofold 
larger than for 1S(726-CFP-YFP-727), although not as 
large as for 1S(671-CFP-YFP-686) (Fig. 5 E and Table I). 
Moreover, 1S(726-YFP-727) supported modest myoplas-
mic Ca
2+ transients ([F/F]max = 0.19 ± 0.08; n = 7; Fig. 5 F 
and Table II), which displayed a sigmoidal voltage de-
pendence that was positively shifted (10–20 mV) relative 
to 1S(671-CFP-YFP-686). A small number of evoked con-
tractions were observed in dysgenic myotubes expressing 
1S(726-YFP-727) (5 of 56 myotubes tested; Table II).
Although the sigmoidal voltage dependence of the Ca
2+ 
transients (Fig. 5 F) suggested that the modest Ca
2+ release 
observed for 1S(726-YFP-727) was skeletal type, we further 
tested the nature of this release by equimolar substitution 
of Mg
2+ for Ca
2+ in the external solution. Substitution of 
Mg
2+ for Ca
2+ had little effect on either the magnitude 
([F/F]max = 0.29 ± 0.17; n = 4; P > 0.05, t test) or the sig-
moidal voltage dependence of SR Ca
2+ release (Fig. S1). 
Figure  5.  Effect  on  bidirectional 
signaling  of  fluorescent  protein 
insertion  between  1S  residues 
726  and  727.  (A  and  D)  Simulta-
neous  recordings  of  myoplasmic 
Ca
2+  transients  (top)  and  L-type 
Ca
2+  currents  (bottom)  elicited  by 
200-ms depolarizations to the indi-
cated test potentials are shown for 
dysgenic  myotubes  expressing  ei-
ther  1S(726-CFP-YFP-727)  (A)  or 
1S(726-YFP-727) (D). (B and E) I-V 
relationships are shown for 1S(726-
CFP-YFP-727) and 1S(726-YFP-727) 
in B and E, respectively. The gray 
lines represent the average I-V rela-
tionship  for  1S(671-CFP-YFP-686). 
(C and F) F/F-V relationships for 
1S(726-CFP-YFP-727)  and  1S(726-
YFP-727) are shown in C and F, re-
spectively. The gray lines represent 
the  average  F/F-V  relationship 
for 1S(671-CFP-YFP-686). The best 
fit parameters for the data in each 
panel are presented in Tables I and 
II. Error bars represent ±SEM.44 1S II–III LOOP AND CFP–YFP PROBES
(Fig. 7 A). Thus, current density for 1S(785-YFP-786) was 
very low (1.4 ± 0.4 pA/pF at 40 mV; n = 12; Fig. 7 B), 
although it produced charge movements (Qmax = 5.2 ± 
0.8 nC/F; n = 5; Fig. 4 E) that were similar to those of the 
other one-piece constructs that supported bidirectional 
signaling (Fig. 4, A and C; and Table I). The Gmax/Q 
ratio for 1S(785-YFP-786) was similar to that of 1S(726-
CFP-YFP-727) and 1S(760-YFP-761) (Table I).
In addition to eliminating retrograde coupling, inser-
tion of YFP between 1S residues 785 and 786 also abol-
ished orthograde coupling, as Ca
2+ transients were nearly 
undetectable (Fig. 7 C). No spontaneous or evoked con-
tractions were observed in dysgenic myotubes expressing 
1S(785-YFP-786) (n = 29; Table II). These results indicate 
that insertion of a single fluorescent protein between 1S 
residues 785 and 786 disrupts bidirectional coupling.
Insertion of fluorescent proteins does not impede 
antibody binding to the critical domain
Within the critical domain, 1S residues 737–744 are rec-
ognized by mAb 1A, and mutations within this region 
were shown to have parallel effects on the immunohis-
tochemical binding of the antibody and on orthograde 
coupling (Kugler et al., 2004a). On the basis of this result, 
it was hypothesized that the appropriate conformation 
of 1S residues 737–744 is essential for communication 
between DHPR and RYR1. Thus, we used the strategy 
1S(726-CFP-YFP-727) (Fig. 5 B), as indicated by their 
equivalent Gmax/Q ratios (Table I).
Depolarization-elicited  Ca
2+  transients  were  detect-
able in dysgenic myotubes expressing 1S(760-YFP-761) 
([F/F]max = 0.10 ± 0.02; n = 6; Fig. 6 A). However, these 
small transients appeared to be a consequence of Ca
2+ 
entry via the L-type current because the F/F-V rela-
tionship (Fig. 6 C) did not display the sigmoidal shape 
expected for skeletal-type EC coupling but instead mir-
rored the peak I-V relationship (Fig. 6 B). No spontane-
ous or evoked contractions were observed in dysgenic 
myotubes expressing 1S(760-YFP-761) (n = 72; Table II). 
Thus, it appears that both orthograde and retrograde 
signaling are largely ablated by insertion of YFP between 
1S II–III loop residues 760 and 761.
Bidirectional coupling with RYR1 is also disrupted in 
1S(785-YFP-786)
An important limitation of the analysis of chimeras of 1C 
or 1M with 1S is that the region corresponding to 1S 
residues  773–799  is  quite  well  conserved  between  the 
three 1 subunits (Wilkens et al., 2001). Thus, the chime-
ras are not informative about the potential importance of 
this region. Therefore, we directly probed this region by 
inserting YFP between 1S residues 785 and 786 (1S(785-
YFP-786)).  Dysgenic  myotubes  expressing  1S(785-YFP-
786) produced minimal Ca
2+ currents and transients 
Figure  6.  Bidirectional  signal-
ing is disrupted by insertion of 
YFP  between  1S  residues  760 
and  761.  (A)  Simultaneous  re-
cordings  of  myoplasmic  Ca
2+ 
transients (top) and L-type Ca
2+ 
currents  (bottom)  elicited  by 
200-ms depolarizations to the in-
dicated test potentials are shown 
for a dysgenic myotube express-
ing  1S(760-YFP-761).  Note  the 
large charge movement relative 
to small L-type currents and Ca
2+ 
transients.  (B)  I-V  relationship 
for  1S(760-YFP-761).  The  gray 
line  represents  the  average  I-V 
relationship  for  1S(671-CFP-
YFP-686).  (C)  Voltage  depen-
dence  of  Ca
2+  transients  from 
dysgenic  myotubes  expressing 
1S(760-YFP-761).  The  smooth 
curve  for  the  1S(760-YFP-761) 
data  represents  F/F  =  [F/
F]max  ×  exp{0.5(V   V o/b)
2}, 
where [F/F]max = 0.1, Vc = 49.2 
mV, and b = 25.7 mV (Eq. 3). The 
gray line represents the F/F-V 
relationship  for  1S(671-CFP-
YFP-686). Myoplasmic Ca
2+ tran-
sients were recorded only from 
myotubes that had quantifiable 
L-type current. Error bars repre-
sent ±SEM.  Bannister et al. 45 
that are essential for bidirectional coupling with RYR1. 
The insertions were at four sites: (1) replacing residues 
672–685 within the peptide A region, (2) between resi-
dues 726 and 727 near the N-terminal boundary of the 
critical domain (residues 720–765), (3) between resi-
dues 760 and 761 near the C-terminal boundary of the 
critical domain, and (4) between residues 785 and 786 
in the conserved C-terminal region of the 1S II–III 
loop. Bidirectional coupling between DHPR and RYR1 
displayed a differential sensitivity to insertions at these 
four sites. This coupling was unaffected by insertion of 
a large (56 kD) CFP–YFP tandem in place of the pep-
tide A region but was ablated by the same insertion be-
tween 1S residues 726 and 727. Bidirectional coupling 
was partially spared by insertion of only a single fluores-
cent protein (YFP) between 1S residues 726 and 727 
but totally eliminated by insertion either between 1S 
residues 760 and 761 or between residues 785 and 786.
Each of the 1S tandem constructs in which the CFP–
YFP tandem was substituted for 1S residues 672–685 
(Fig. 1, A–D) functioned normally both as a voltage-gated 
Ca
2+ channel and as a voltage sensor for EC coupling 
(Figs. 2 and 3) regardless of whether the 1S construct 
was expressed as a combination of two hemidomains 
(1S repeats I–II and repeats III–IV) or as an intact chan-
nel. This finding is in agreement with several previous 
studies demonstrating that EC coupling is unaffected by 
scrambling, deleting, or substituting unrelated sequence 
for the peptide A region of the 1S II–III loop (Proenza 
et al., 2000b; Ahern et al., 2001a,b; Wilkens et al., 2001; 
Flucher et al., 2002; Lorenzon et al., 2004; Papadopoulos 
illustrated in Fig. 8 A to test whether mAb 1A could 
recognize its epitope in the constructs with impaired bi-
directional coupling (i.e., 1S(726-CFP-YFP-727), 1S(726-
YFP-727),  1S(760-YFP-761),  and  1S(785-YFP-786);   
Figs. 5–7). Fig. 8 B shows for YFP-1S that the yellow fluor-
escence (middle, green) and mAb 1A staining (top, red) 
colocalize in discrete puncta (bottom, yellow). Similarly 
colocalized puncta of yellow fluorescence and mAb 1A 
staining  were  also  observed  for  1S(726-CFP-YFP-727), 
1S(726-YFP-727),  1S(760-YFP-761),  and  1S(785-YFP-
786) (Fig. 8, C–F). Such puncta were completely absent 
in dysgenic myotubes not injected with 1S cDNAs (un-
published data). Furthermore, in control experiments 
in which the primary antibody was omitted, red puncta 
were absent despite the persistence of puncta generated 
by YFP fluorescence (unpublished data). Previous work 
has demonstrated that DHPR puncta in myotubes colo-
calize with RYR1 (Takekura et al., 2004). Thus, the data 
in Fig. 8 support the idea that each of the fluorescent 
protein 1S constructs was efficiently targeted to plasma 
membrane junctions with the SR. In addition, these data 
demonstrate that the introduction of either a single 
YFP or a CFP–YFP tandem did not severely disrupt the 
conformation of the antibody epitope within the crit-
ical domain.
DISCUSSION
In this study, we have evaluated the effects of fluores-
cent protein insertion as a tool for obtaining information 
about domains of the 1S II–III loop (residues 662–799) 
Figure  7.  Bidirectional  signal-
ing is disrupted by insertion of 
YFP  between  1S  residues  785 
and  786.  (A)  Simultaneous  re-
cordings  of  myoplasmic  Ca
2+ 
transients (top) and L-type Ca
2+ 
currents  (bottom)  elicited  by 
200-ms depolarizations to the in-
dicated test potentials are shown 
for a dysgenic myotube express-
ing 1S(785-YFP-786). (B) I-V re-
lationship for 1S(785-YFP-786). 
The gray line represents the aver-
age I-V relationship for 1S(671-
CFP-YFP-686). (C) Lack of Ca
2+ 
transients in dysgenic myotubes 
expressing  1S(785-YFP-786). 
The  gray  line  represents  the 
average  F/F-V  relationship 
for  1S(671-CFP-YFP-686).  Myo-
plasmic Ca
2+ transients were re-
corded only from myotubes that 
had quantifiable L-type current. 
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nificantly impacted bidirectional signaling. To evaluate 
these effects, it is useful to consider the landmarks of 
the critical domain. This region was initially character-
ized as 1S residues 720–765 on the basis of functional 
analysis of chimeras between 1S and 1C (Nakai et al., 
1998b). The top portion of Fig. 9 compares the sequence 
of these 46 1S residues (720–765) with the correspond-
ing residues of 1C (851–896) and 1M (712–756). Sub-
sequent work identified a slightly smaller region of 31 
1S residues that was sufficient to restore full bidirec-
tional signaling when inserted into a II–III loop other-
wise having an 1M sequence (chimera SkLMS31; Kugler 
et al., 2004b). Fig. 9 illustrates the position of this slightly 
smaller segment of the critical domain and also com-
pares the sequences of 1S, 1C, and 1M that extend 
from the C-terminal edge of the critical domain to the 
beginning of repeat IIIS1.
Insertion of the tandem within the N-terminal portion 
of the critical domain abolished bidirectional signaling 
(Fig. 5, A–C). This loss of signaling did not appear to be a 
consequence  of  loss  of  membrane  expression  because 
charge  movements  for  1S(726-CFP-YFP-727)  were  not 
et al., 2004; Lorenzon and Beam, 2007). Clearly, these 
previous results had already indicated that the binding 
of the peptide A region to other junctional proteins is 
unnecessary for coupling with RYR1. It now seems pos-
sible to broaden this conclusion. First, the ability of the 
peptide A region to accommodate the CFP–YFP tan-
dem, together with this region’s accessibility to a large 
(60 kD) streptavidin probe (Lorenzon et al., 2004; 
Lorenzon and Beam, 2007), suggests that the segments 
of the 1S II–III loop adjacent to the peptide A region 
are also fully exposed to the myoplasm at the triad junc-
tion and thus devoid of junctional interaction partners 
in both resting and depolarized cells. Second, it seems 
extremely unlikely that peptide A and/or immediately 
adjacent regions of the 1S II–III loop are important for 
propagating signaling-related conformational changes 
to RYR1 because one might expect such conforma-
tional changes to be impeded by the presence of the 
CFP–YFP tandem.
Unlike insertions in the peptide A region, insertions 
of fluorescent protein in either the N- or C-terminal 
portions of the critical domain of the 1S II–III loop sig-
Figure 8.  Insertion of fluorescent pro-
tein at residues 726, 760, or 785 within 
the 1S II–III loop does not interfere 
with recognition of the critical domain 
by a site-specific mAb. (A) Schematic 
representation of 1S and the epitope 
recognized by mAb 1A (residues 737–
744; Kugler et al., 2004a). 1S(726-YFP-
727) is shown as an arbitrary example. 
(B–F) Confocal fluorescence images of 
mAb 1A binding (top, red), 1S fluo-
r  escent  protein  distribution  (middle, 
green), and the overlay of the antibody 
binding and 1S distribution (bottom) 
are  shown  for  dysgenic  myotubes  ex-
pressing  YFP-1S  (B),  1S(726-CFP-
YFP-727)  (C),  1S(726-YFP-727)  (D), 
1S(760-YFP-761) (E), and 1S(785-YFP-
786) (F). The images represent optical 
sections near the myotube surface. In 
deeper optical sections, the overlapping 
red and yellow puncta were largely ab-
sent from the core of the myotube and 
were present only at the periphery (not 
depicted). Alexa Fluor 568–conjugated 
anti–mouse  IgG  was  used  to  visualize 
the binding of mAb 1A. Bars, 5 µm.  Bannister et al. 47 
struct 1S(760-YFP-761). It should be noted that the YFP 
connecting linkers were substantially shorter for the in-
sertion between residues 760/761 than for the insertion 
between residues 726/727 (see Materials and methods). 
Although the different linker length could have con-
tributed to the greater effect of YFP insertion at residues 
760/761 than at residues 726/727, it seems unlikely to 
account for the much greater effect of YFP insertion at 
residues 785/786 compared with residues 726/727 be-
cause the linker lengths were nearly identical at the two 
positions. Thus, it seems reasonable to conclude that bi-
directional signaling is much more sensitive to pertur-
bation at residues 785/786 than at residues 726/727.
The suppression of bidirectional signaling produced by 
inserting fluorescent proteins within the N- or C-terminal 
portions of the critical domain could, in principle, result 
from disruption of the tertiary structure of this entire 
region. However, the structure of this region did not 
appear to be severely altered because mAb 1A was able 
to recognize its epitope (1S residues 737–744) within the 
critical domain of the constructs 1S(726-CFP-YFP-727), 
1S(726-YFP-727), 1S(760-YFP-761), and 1S(785-YFP-786) 
(Fig. 8, C–F).
The absence of bidirectional signaling for 1S(726-
CFP-YFP-727) and 1S(760-YFP-761) is consistent with 
the idea that the binding of 1S residues (727–760) to 
other junctional proteins (e.g., RYR1) is necessary for 
functional coupling. For example, one could hypothesize 
significantly different from those of 1S(671-CFP-YFP-686) 
(Fig. 4, A and B; and Table I). Additionally, junctional 
targeting, as indicated by fluorescent puncta near the sur-
face,  appeared  to  be  normal  for  1S(726-CFP-YFP-727) 
(Fig. 8 C). Thus, it appears that tandem insertion between 
residues 726 and 727 specifically eliminated interaction 
with RYR1 because Ca
2+ transients were absent and the 
currents for 1S(726-CFP-YFP-727) had amplitude and ki-
netics like those of Ca
2+ current in dyspedic myotubes, 
where  RYR1  is  genetically  absent  (Nakai  et  al.,  1996, 
1998a; Avila and Dirksen, 2000; Sheridan et al., 2006). 
One possibility for why bidirectional coupling is absent 
for 1S(726-CFP-YFP-727) is that the insertion of the tan-
dem between residues 726 and 727 severed a sequence of 
the loop that binds to other junctional proteins. However, 
substantial alteration of the primary sequence surround-
ing 1S residues 726 and 727, as occurs in the chimera 
SkLMS31 (Fig. 9), appears to have no effect on bidirec-
tional signaling (Kugler et al., 2004b). Another argument 
against the idea that interruption of the primary sequence 
accounts for the complete loss of coupling by 1S(726-
CFP-YFP-727) is that coupling was partially preserved in 
the construct 1S(726-YFP-727), as shown in Fig. 5 (D–F).
Compared with the N-terminal edge of the critical do-
main, the C-terminal edge appeared more sensitive to 
introduction of a single fluorescent protein. Thus, weak 
bidirectional  signaling  was  present  for  the  construct 
1S(726-YFP-727) but was completely absent for the con-
Figure 9.  Sequence comparison of the critical domain and C-terminal region of the 1S II–III loop with the corresponding regions 
of 1C and 1M. Sequence alignment is shown for rabbit 1S (GenBank/EMBL/DDBJ accession no. X05921), rabbit 1C (GenBank/
EMBL/DDBJ accession no. X15539), and M. domestica 1M (GenBank/EMBL/DDBJ accession no. Z31723). The top panel (1S residues 
720–765) represents the critical domain as defined by Nakai et al. (1998b). The bottom panel (1S residues 766–799) represents the 
region of the II–III loop C-terminal to the critical domain, ending just before repeat III (Tanabe et al., 1987). Sequence is not shown 
for the relatively divergent N-terminal portion of the II–III loop (1S residues 662–719). Residues of 1C or 1M identical to those of 1S 
are shaded in black, and residues conserved with those of 1S are shaded in gray. For the SkLMS31 chimera (Kugler et al., 2004b), the 
black line indicates 1S sequence inserted into the M. domestica loop. The epitope for binding of mAb 1A (Kugler et al., 2004a) is boxed 
in orange. The conserved 1S/1C negative charge cluster is boxed in blue. Individual point mutation of any of the nonconserved 1S 
residues indicated in red to the corresponding 1C residues results in a decreased magnitude of skeletal-type EC coupling (Kugler 
et al., 2004b) and loss of mAb 1A binding (Kugler et al., 2004a). Black arrows indicate the positions of fluorescent protein insertion for 
1S(726-CFP-YFP-727), 1S(726-YFP-727), 1S(760-YFP-761), or 1S(785-YFP-786) (Fig. 1).48 1S II–III LOOP AND CFP–YFP PROBES
ment of DHPRs into tetrads depends on the presence of 
RYR1  in  the  SR  at  sites  of  junction  with  the  plasma 
membrane (Protasi et al., 1998, 2000, 2002). Tetrads 
are not formed upon expression in dysgenic myotubes 
of a chimera consisting of 1S with a II–III loop having 
an 1C sequence (SkLC), but tetrads are formed when 
the critical domain portion of the loop of SkLC is con-
verted back to an 1S sequence (Takekura et al., 2004). 
Interestingly, however, relatively good tetrad formation 
was observed for a chimera (SkLM) consisting of 1S 
with a II–III loop having an 1M sequence (Takekura 
et al., 2004), even though this construct did not support 
skeletal-type EC coupling (Wilkens et al., 2001).
Ahern et al. (2001b) found that a one-piece 1S con-
struct lacking the critical domain did not mediate skele-
tal-type EC coupling, but a construct lacking both the 
critical domain and the peptide A region did support 
weak coupling, producing maximal transients of 15% 
of the amplitude of wild-type 1S. Thus, in addition to the 
critical domain, other regions of the DHPR have some 
ability to participate in the interactions that support 
EC coupling. The organization of SkLM into tetrads 
(Takekura et al., 2004) also implies that yet-to-be-identi-
fied regions of the DHPR must participate in the interac-
tions linking the DHPR to RYR1. Our present results 
(Figs. 2–7) raise the possibility that one of these yet-to-be-
identified regions is the portion of the 1S II–III loop that 
is C-terminal to the critical domain (Fig. 9, bottom).
In addition to the critical domain and C-terminal re-
gion of the 1S II–III loop, other DHPR domains are also 
possible sites involved in coupling to RYR1. For example, 
the C-terminal region of 1a strongly influences bidirec-
tional  signaling  (Beurg  et  al.,  1999;  Sheridan  et  al., 
2003a,b, 2004; García et al., 2005). 1a also facilitates tet-
rad formation, as the 1a-null zebrafish mutant relaxed 
lacks the characteristic orthogonal DHPR arrays typically 
observed in freeze-fracture replicas of normal skeletal 
muscle (Schredelseker et al., 2005, 2008). Other possi-
ble sites that may interact with RYR1 are the 1S III–IV 
loop (Leong and MacLennan, 1998b; but see Bannister 
et al., 2008b) and proximal portions of the C terminus of 
1S (Slavik et al., 1997; Flucher et al., 2000; Proenza 
et al., 2000a; Sencer et al., 2001; Lorenzon et al., 2004; 
Papadopoulos et al., 2004; Lorenzon and Beam, 2007).
Overall, the effects of inserting fluorescent proteins 
into the 1S II–III loop are consistent with the idea that 
binding of the 1S II–III loop critical domain to other 
junctional proteins is important for bidirectional signal-
ing. Our current results expand our knowledge of the 
mechanism of bidirectional coupling by identifying the 
importance of the conserved region of the 1S II–III 
loop that connects the critical domain to 1S repeat III. 
However, our results do not exclude roles for other re-
gions of the DHPR that have been implicated as involved 
in coupling with RYR1. Indeed, it seems quite likely that 
several cytoplasmic regions of the DHPR, in addition to 
that voltage sensor movement in response to depolar-
ization promotes a conformation of the 1S II–III loop 
that favors the bound state of this region of the critical 
domain and, thus, both SR Ca
2+ release and retrograde 
signaling. If this model were correct, the addition of the 
extra mass of fluorescent protein near either the N- or 
C-terminal boundaries of the critical domain could slow 
the on-rate for binding, shift the equilibrium toward 
the unbound state, and thus reduce the magnitude of 
bidirectional coupling. This kinetic model would explain 
why the CFP–YFP tandem with its greater mass had a 
larger effect when inserted after residue 726 than did 
YFP alone. A second hypothesis (occlusion model) is 
that the presence of the fluorescent proteins sterically 
occludes entry of 1S II–III loop residues into a binding 
pocket. According to this model, the binding of residues 
727–760 would be completely occluded by the presence 
of the CFP–YFP tandem between residues 726–727 but 
only partially occluded by a single YFP at this position.
Either the kinetic or occlusion model could be made 
compatible with the observation that bidirectional cou-
pling was totally absent for 1S(760-YFP-761). With the 
kinetic model, for example, it could be postulated that 
the C-terminal segment of the 1S II–III loop (roughly 
from residue 760 to repeat III) is essential for coupling 
between voltage sensor movement and the active con-
formation of the critical domain and that this coupling 
is drastically slowed by the presence of fluorescent pro-
tein between 1S residues 760 and 761. Alternatively, the 
YFP placed between 1S residues 760 and 761 might di-
rectly interfere with the binding of the adjacent critical 
domain residues to other junctional proteins.
Whether  or  not  these  aforementioned  specific  hy-
potheses have validity, it is important to recognize that 
the region of the 1S II–III loop downstream from the 
critical domain is well conserved between 1S, 1C, and 
1M (Fig. 9, bottom), which means that its importance 
has  not  been  previously  tested  by  chimeras  between 
these channels. In this regard, the ablation of both or-
thograde and retrograde coupling by introduction of 
YFP between 1S residues 785 and 786 (Fig. 7) clearly 
indicates that the integrity of this region is vital for skel-
etal-type  EC  coupling.  It  remains  to  be  determined 
whether this domain functions as a conduit for intramo-
lecular communication between the voltage sensor and 
the critical domain or whether it serves as a site for in-
termolecular  interactions  that  support  bidirectional 
communication between DHPR and RYR1.
In addition to functional evidence for the importance 
of the critical domain of the 1S II–III loop, yeast two-
hybrid assays have revealed a weak interaction between 
the critical domain and a segment of RYR1 (residues 
1,837–2,168; Proenza et al., 2002). Freeze-fracture elec-
tron microscopy also provides structural evidence that 
the critical domain of the 1S II–III loop is important 
for linking DHPRs to RYR1. In particular, the arrange-  Bannister et al. 49 
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essential region in the II-III loop of the dihydropyridine receptor 
1 subunit required for activation of skeletal muscle-type excita-
tion-contraction coupling. Biochemistry. 37:7015–7020.
Flucher, B.E., N. Kasielke, and M. Grabner. 2000. The triad target-
ing signal of the skeletal muscle calcium channel is localized in 
the COOH terminus of the 1S subunit. J. Cell Biol. 151:467–478.
Flucher, B.E., R.G. Weiss, and M. Grabner. 2002. Cooperation of 
two-domain Ca
2+ channel fragments in triad targeting and resto-
ration of excitation-contraction coupling in skeletal muscle. Proc. 
Natl. Acad. Sci. USA. 99:10167–10172.
Freise,  D.,  B.  Held,  U.  Wissenbach,  A.  Pfeifer,  C.  Trost,  N. 
Himmerkus, U. Schweig, M. Freichel, M. Biel, F. Hofmann, et al. 
2000. Absence of the  subunit of the skeletal muscle dihydropyri-
dine receptor increases L-type Ca
2+ currents and alters channel 
inactivation properties. J. Biol. Chem. 275:14476–14481.
those already implicated, participate in interactions that 
positively or negatively influence coupling between the 
DHPR and RYR1 (Bannister, 2007). However, we are 
now in a position to exclude at least a couple of regions 
from likely involvement. One such region is the N ter-
minus of 1S, which can be largely deleted without 
affecting function (Bannister and Beam, 2005). Based 
on both previous results (Proenza et al., 2000b; Ahern 
et al., 2001a,b; Flucher et al., 2002; Lorenzon et al., 
2004; Papadopoulos et al., 2004; Lorenzon and Beam, 
2007) and those described in this study, it also seems 
possible to exclude the involvement of peptide A and 
adjacent regions of the N-terminal portion of the 1S 
II–III loop as an essential trigger for EC coupling.
The fact that gating of RYR1 is responsive to voltage 
across the plasma membrane means that the functional 
state of the DHPR must control the conformation of at 
least some of the cytoplasmic DHPR regions important 
for coupling. Regions of this sort may be difficult to de-
fine by standard biochemical or structural approaches. 
Thus, it is likely to continue to be of value to use the 
kinds of approaches described here to probe the impor-
tance of other cytoplasmic domains of the DHPR.
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